Hancock Whitney’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Hancock Whitney’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,451	Closed	-$279K	–	687
2022 Q1	$279K	Sell	3,451 -25	-0.7%	-$2.12K	0.01%	601
2021 Q4	$357K	Buy	3,476 +82	+2%	+$7.87K	0.01%	552
2021 Q3	$297K	Buy	3,394 +142	+4%	+$12.9K	0.01%	571
2021 Q2	$291K	Sell	3,252 -109	-3%	-$9.21K	0.01%	689
2021 Q1	$255K	Sell	3,361 -507	-13%	-$38.2K	0.01%	685
2020 Q4	$264K	Sell	3,868 -194	-5%	-$12.1K	0.01%	678
2020 Q3	$216K	Sell	4,062 -123	-3%	-$7.32K	0.01%	697
2020 Q2	$244K	Sell	4,185 -2,554	-38%	-$137K	0.01%	671
2020 Q1	$266K	Buy	6,739 +3,036	+82%	+$178K	0.01%	679
2019 Q4	$220K	Sell	3,703 -163	-4%	-$8.76K	0.01%	746
2019 Q3	$206K	Buy	+3,866	New	+$198K	0.01%	762

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hancock Whitney's SYNH Position: Q2 2022 in Review

Hancock Whitney sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2022, closing a stake of 3,451 shares — an estimated $279K sold.

Hancock Whitney first reported a position in SYNH in Q3 2019 and held it in 11 quarters. The position peaked at $357K in Q4 2021. 362 funds tracked by Wall St. Rank hold SYNH as of Q2 2022.

Hancock Whitney reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Hancock Whitney sold 3,451 Syneos Health, Inc. Class A Common Stock shares in Q2 2022, an estimated $279K.
Hancock Whitney first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2019 and held it in 11 quarters.
Hancock Whitney's Syneos Health, Inc. Class A Common Stock position peaked at $357K in Q4 2021.
362 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2022.

Based on Hancock Whitney's 13F filing for Q2 2022, filed 8 Aug 2022.